ArticleFrontiers in oncology2021

Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data.

Jeong-Yeon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.